956
Views
161
CrossRef citations to date
0
Altmetric
Research Article

Targeted nanoparticle-based drug delivery and diagnosis

&
Pages 163-183 | Received 13 Oct 2006, Accepted 18 Jan 2007, Published online: 08 Oct 2008

References

  • Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 2002; 99: 12617–12621
  • Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002; 2: 750–763
  • Allen TM, Cullis PR. Drug delivery systems: Entering the mainstream. Science 2004; 303: 1818–1822
  • Alpar HO, Field WN, Hayes K, Lewis DA. The transport of microspheres from the gastrointestinal tract to infammatory air pouches in the rat. J Pharm Pharmacol 1990; 41: 194–196
  • Alyautdin RN, Petrov VE, Langer K, Berthold A, Kharkevich DA, Kreuter J. Delivery of loperamide across the blood–brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm Res 1997; 14: 325–328
  • Alyautdin RN, Tezikov EB, Ramge P, Kharkevich DA, Begley DJ, Kreuter J. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: An in situ brain perfusion study. J Microencapsul 1998; 15: 67–74
  • Anderson SA, Rader RK, Westlin WF, Null C, Kackson D, Lanza GM, Wickline SA, Kotyk JJ. Magnetic resonance contrast enhancement of neovascular with v3-targeted nanoparticles. Magn Reson Med 2000; 44: 433–439
  • Andresen TL, Davidsen J, Begtrup M, Mouritsen OG, Jørgensen K. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs. J Med Chem 2004; 47: 1694–1703
  • Antohe F, Heltianu C, Simionescu M. Albumin-binding proteins of endothelial cells: Immunocytochemical detection of the 18 kDa peptide. Eur J Cell Biol 1991; 56: 34–42
  • Antohe F, Dobrila L, Heltianu C, Simionescu N, Simionescu M. Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells. Eur J Cell Biol 1993; 60: 268–275
  • Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumour vasculature in a mouse model. Science 1998; 279: 377–338
  • Assa-Munt N, Jia X, Laakkonen P, Ruoslahti E. Solution structures and integrin binding activities of an RGD peptide with two isomers. Biochemistry 2001; 40: 2373–2378
  • Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 2004; 15: 79–86
  • Barathur R, Bookout J, Sreevatsan S, Gordon J, Werner M, Thor G, Worthington M. New disc-based technologies for diagnostic and research applications. Psychiatr Genet 2002; 12: 193–206
  • Barenholz Y. Liposome application: Problems and prospects. Curr Opin Coll Interface Sci 2001; 6: 66–77
  • Bargoni A, Cavalli R, Zara GP, Fundaro A, Caputo O, Gasco MR. Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II-tissue distribution. Pharm Res 2001; 43: 497–502
  • Berton M, Turelli P, Trono D, Stein CA, Allemann E, Gurny R. Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles. Pharm Res 2001; 18: 1096–1101
  • Bos GW, Kanellos T, Crommelin DJ, Hennink WE, Howard CR. Cationic polymers that enhance the performance of HbsAg DNA in vivo. Vaccine 2004; 23: 460–469
  • Bosi S, Da Ros T, Castellano S, Banfi E, Prato M. Antimycobacterial activity of ionic fullerene derivatives. Bioorg Med Chem Lett 2000; 10: 1043–1045
  • Bruchez M, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science 1998; 281: 2013–2016
  • Brusewitz C, Schendler A, Funke A, Wagner T, Lipp R. Novel poloxamer-based nanoemulsions to enhance the interstinal absorption of active compounds. Int J Pharm 2007; 329: 173–181
  • Bustami R, Chan H, Dehghani F, Foster NR. Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide. Pharm Res 2000; 17: 1360–1366
  • Cao YC, Jin R, Mirkin CA. Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. Science 2002; 297: 1536–1540
  • Cao YC, Jin R, Nam JM, Thaxton CS, Mirkin CA. Raman dye-labeled nanoparticle probes for proteins. J Am Chem Soc 2003; 125: 4676–1467
  • Carr KE, Hazzard RA, Reid S, Hodges GM. The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes. Pharm Res 1996; 13: 1205–1209
  • Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol 2002; 13: 40–46
  • Chapat S, Frey V, Claperon N, Bouchaud C, Puisieux F, Couvreur P, Rossignol P, Delattre J. Efficiency of liposomal ATP in cerebral ischemia: Bioavailability features. Brain Res Bull 1991; 26: 339–342
  • Chen R, Zhang Y, Wang D, Dai H. Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J Am Chem Soc 2001; 123: 3838–3839
  • Chen S, Webster S, Czerw R, Xu J, Carroll DL. Morphology effects on the optical properties of silver nanoparticles. J Nanosci Nanotechnol 2004; 4: 254–259
  • Cherukuri P, Bachilo SM, Litovsky SH, Weisman RB. Near-infrared fluorescence microscopy of single-walled carbon nanotunes in phagocytic cells. J Am Chem Soc 2004; 126: 15638–15639
  • Chickering DE, Harris WP, Mathiowitz E. A micro-tensiometer for the analysis of bioadhesive microspheres. Biomed Instrum Technol 1995; 29(501)512
  • Chickering DE, Jacob JS, Desai T, Harrison M, Harris WP, Morrell CN, Mathiowitz E. Bioadhesive microspheres: III. An in vivo transit and bioavailability study of alginate and poly(Fumaric-co-Sebacic Anhydride). J Control Release 1997; 48: 35–46
  • Christofidou-Solomidou M, Pietra GG, Solomides CC, Arguiris E, Harshaw D, Fitzgerald GA, Albelda SM, Muzykantov VR. Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol 2000; 278: 794–805
  • Clark H, Kopelman R, Tjalkens R, Philbert MA. Optical nanosensors for chemical analysis inside single living cells. 2. Sensors for pH and calcium and the intracellular application of PEBBLE sensors. Anal Chem 1999; 71: 4837–4843
  • Cohen S, Bernstein H. Microparticulate systems for the delivery of proteins and vaccines. Marcel Dekker, New York, NY 1996
  • Cohen-Sacks H, Najajreh Y, Tchaikovski V, Gao G, Elazer V, Dahan R, Gati I, Kanaan M, Waltenberger J, Golomb G. Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis. Gene Ther 2002; 9: 1607–1616
  • Csaki A, Moller R, Fritzsche W. Gold nanoparticles as novel label for DNA diagnostics. Expert Rev Mol Diagn 2002; 2: 187–193
  • Curnis F, Sacchi A, Corti A. Improving chemotherapeutic drug penetration in tumours by vascular targeting and barrier alteration. J Clin Invest 2002; 110: 475–482
  • Damge C, Aprahamian M, Marchais H, Benoit JP, Pinget M. Intestinal absorption of PLAGA microspheres in the rat. J Anat 1996; 189: 491–501
  • Davidson J, Mouritsen OG, Jørgensen K. Synergistic permeability enhancing effect of lysophospholipids and fatty acids on lipid membranes. Biochim Biophys Acta 2002; 1564: 256–262
  • Davidson J, Jørgensen K, Andresen TL, Mouritsen OG. Secereted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue. Biochim Biophys Acta 2003; 1609: 95–101
  • D'Emanuele A, Jevprasephant R, Penny J, Attwood D. The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. J Control Release 2004; 95: 447–453
  • Dempski R, Scholtz E, Oberholtzer E, Yeh K. Pharmaceutical design and development of a sinemet controlled-release formulation. Neurology 1989; 39: 20–24
  • Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahajopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumours. Pharm Rev 1991; 51: 691–743
  • Duchêne D, Touchard F, Peppas NA. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm 1988; 14: 283–318
  • Dugan LL, Lovette E, Cuddihy S. Carboxyfullerenes as neuroprotective antioxidants. Fullerenes: Chemistry, physics, and technology, KM Kadish, RS Ruoff. John Wiley and Sons, New York, NY 2000
  • Dunning MD, Lakatos A, Loizou L, Kettunen M, French-Constant C, Brindle KM, Franklin RJ. Superparamagnetic iron oxide-labeled Schwaan cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain their functional properties after transplantation into the CNS. J Neurosci 2004; 24: 9799–9810
  • Ebel JP. A method for quantifying particle absorption from the small intestine of mouse. Pharm Res 1990; 7: 848–851
  • Eliceiri P, Cheresh DA. The role of alpha v integrins during angiogenesis: Insights into potential mechanisms of action and clinical development. J Clin Invest 1999; 103: 1227–1230
  • Emerich DF, Thanos C. Nanotechnology and medicine: The here and now and future prospects. Expert Opin Biol Ther 2003; 3: 655–663
  • Ermak TH, Dougherty EP, Bhagat HR, Kabok Z, Pappo J. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's Patch M cells. Cell Tissue Res 1995; 279: 433–436
  • Fabel K, Dietrich J, Hau P, Wismeth C, Winner B, Przywara S, Steinbrecher A, Ullrich W, Bogdahn U. Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer 2001; 92: 1936–1942
  • Feynman R. Engineering and science. 1959, California Institute of Technology
  • Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM. Novel MRI contrast agent for molecular imaging of fibrin implications for detecting vulnerable plaques. Circulation 2001; 104: 1280–1285
  • Methods in neuroscience. Providing therapeutic access to the brain: New approaches, TR Flanagan, DF Emerich, SR Winn. Academic Press, New York, NY 1994; vol. 21
  • Florence AT, Hillery AM, Hussain N, Jani PU. Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate. J Control Release 1995; 36: 39–46
  • Foster N, Clark M, Jepson M, Hirst B. Ulex europaeus 1 lectin targets mcirospheres to mouse Peyer's patch M-cells in vivo. Vaccine 1998; 16: 536–541
  • Freitas RA. Nanomedicine. Basic capabilities. Landes BioScience, Georgetown, TX 1999; vol. I
  • Fresta M, Puglisi G, Di Giacomo C, Russo A. Liposomes as in-vivo carriers for citicoline: Effects on rat cerebral post-ischaemic reperfusion. J Pharm Pharmacol 1994; 46: 974–981
  • Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin: Review of animal and human studies. Clin Pharmacokin 2003; 42: 419–436
  • Galindo-Rodriguez SA, Allemann E, Fessi H, Doelker E. Polymeric nanoparticles for oral delivery of drugs and vaccines: A critical evaluation of in vivo studies. Crit Rev Ther Drug Carrier Syst 2005; 22: 419–464
  • Gao X, Cui Y, Levenson RM, Chung L, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004; 22: 969–976
  • Gelperina S, Smirnova Z, Skidan JK. Proceedings of 3rd World Meeting APV/APGI: Berlin. 2000; 441–442
  • Gilles ER, Frechet JM. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 2005; 10: 35–43
  • Goldstein A, Amory J, Martin S, Vernon C, Matsumoto A, Yager P. Testosterone delivery using glutamide-based complex high axial ratio microstructures. Bioorg Med Chem 2001; 9: 2819–2825
  • Goren D, Horwitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res 2000; 6: 1949–1957
  • Gourley PL. Brief overview of BioMicroNano technologies. Biotechnol Prog 2005; 21: 2–10
  • Grubisha DS, Lipert RJ, Park HY, Driskell J, Porter MD. Femtomolar detection of prostate-specific antigen: An immunoassay based on surface-enhanced Raman scattering and immunogold labels. Anal Chem 2003; 75: 5936–5943
  • Gulyaev AE, Gelperina SE, Skidan IN, Antropov AS, Kivman GY, Kreuter J. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. J Pharm Res 1999; 16: 1564–1569
  • Hamaguchi T, Matusmura Y, Suzuki M, Shimizu K, Goda R, Nakamura I, Nakatomi I, Yokoyama M, Kataoka K, Kakizoe T. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumor activity and reduce the neurotoxicity of paclitaxel. Br J Cancer 2005; 92: 1240–1246
  • Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, Hulsbergen van de Kaa C, de la Rosette J, Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491–2499
  • Hau P, Fabel K, Baumgart U, Rummele P, Grauer O, Bock A, Dietmaier C, Dietmaier W, Dietrich J, Dudel C, Hubner F, Jauch T, Drechsel E, Kleiter I, Wismeth C, Zellner A, Brawanski A, Steinbrecher A, Marienhagen J, Bogdahn U. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer 2004; 100: 1199–1207
  • Hillyer J, Albrecht R. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 2001; 90: 1927–1936
  • Hirsch LR, Jackson JB, Lee A, Halas NJ, West JL. A whole blood immunoassay using gold nanoshells. Anal Chem 2003; 75: 2377–2381
  • Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, Cheresh DA. Tumor regression by targeted gene delivery to the neovasculature. Science 2002; 296: 2404–2407
  • Hoshi S, Uchino A, Kusanagi K, Ihara T, Ueda S. Uptake of orally administered polystyrene latex and poly(d,l-lactic/glycolic acid) microspheres into intestinal lymphoid tissues in chickens. Vet Immunol Immunopathol 1999; 70: 33–42
  • Hussain N, Jaitley V, Florence A. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 2001; 50: 107–142
  • Huwyler J, Cerletti A, Fricker G, Eberle AN, Drewe J. By-passing of P-glycoprotein using immunoliposomes. J Drug Target 2002; 10: 73–79
  • Imaizumi S, Woolworth V, Fishman RA, Chan PH. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke 1990; 2: 1312–1317
  • Ito T, Sun L, Crooks RM. Simultaneous determination of the size and surface charge of individual nanoparticles using a carbon nanotube-based Coulter counter. Anal Chem 2003; 75: 2399–2406
  • Jacob J, Santos C, Carino G, Chickering D, Mathiowitz E. An in vitro bioassay for quantification of bioadhesion of polymer microspheres to mucosal epithelium. Proc Int Symp Control Release Bioact Mat 1995; 22: 312–313
  • Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol 1990; 42: 821–826
  • Jani P, Halbert GW, Langridge J, Florence AT. The uptake and translocation of latex nanospheres after oral administration to rats. J Pharm Pharmacol 1989; 41: 809–812
  • Jani PU, Florence AT, McCarthy DE. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int J Pharm 1992; 33: 245–252
  • Jani P, McCarthy DE, Florence AT. Titanium dioxide (Rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int J Pharm 1994; 1994: 157–169
  • Jani P, Nomura T, Yamashita F, Takakura Y, Florence AT, Hashida H. Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male Wistar rats. J Drug Target 1996; 4: 87–93
  • Jiang C, Koyabu N, Yonemitsu Y, Shimazoe T, Watanabe S, Naito M, Tsuruo T, Ohtani H, Sawada Y. In vivo delivery of glial cell-derived neurotrophic factor across the blood–brain barrier by gene transfer into brain capillary endothelial cells. Hum Gene Ther 2003; 14: 1181–1191
  • Jain S, Mishra V, Singh P, Dubey PK, Saraf DK, Vyas SP. RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. Int J Pharm 2003; 261: 43–55
  • Jin R, Cao Y, Mirkin CA, Kelley KL, Schatz GC, Zheng JG. Photoinduced conversion of silver nanospheres to nanoprisms. Science 2001; 294: 1901–1903
  • Jørgensen K, Davidsen J, Mouritsen OG. Biophysical mechanisms of phospholipase A2 activation and their use in liposome-based drug delivery. FEBS Lett 2002; 531: 23–27
  • Kakinuma K, Tanaka R, Takahashi H, Sekihara Y, Watanabe M, Kuroki M. Drug delivery to the brain using thermosensitive liposome and local hyperthermia. Int J Hypertherm 1996; 12: 157–165
  • Kim S, Bell K, Mousa SA, Varner JA. A regulation of angiogenesis in vivo by ligation of integrin α5ß1 with the central cell-binding domain of fibronectin. Am J Pathol 2000; 156: 1345–1362
  • Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004; 22: 93–97
  • Kitchens KM, Kolhatkar RB, Swaan PW, Eddington ND, Ghandehari H. Transport of poly(aminoamine) dendrimers across Caco-2 monolayers: Influence of size, charge, and fluorescent labeling. Pharm Res 2006; 23: 2818–2826
  • Koushik K, Dhanda DS, Cheruvu NP, Kompella UB. Pulmonary delivery of deslorelin: Large-porous PLGA particles and HpbetaCD complexes. Pharm Res 2004; 21: 1119–1126
  • Koziara JM, Lockman PR, Allen DD, Mumper RJ. Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 2004; 99: 259–269
  • Kreuter J, Alyautdin RN, Kharkevich DA, Ivanov AA. Passage of peptides through the blood–brain barrier with colloidal polymer particles (nanoparticles). Brain Res 1995; 674: 171–174
  • Kreuter J, Petrov VE, Kharkevich DA, Alyautdin RN. Delivery of loperamide across the blood–brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. J Control Release 1997; 49: 81–87
  • Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol 2004; 4: 484–488
  • Kukowska-Latallo J, Raczka E, Quintana A, Chen C, Rymaszewski M, Baker JR. Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. Hum Gene Ther 2000; 11: 1385–1395
  • Labhasetwar V. Nanotechnology for drug and gene therapy: The importance of understanding molecular mechanisms of delivery. Curr Opin Biotechnol 2005; 674–680
  • Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, Sharkey AM, Miller JG, Gaffney PJ, Wickline SA. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996; 94: 3334–3340
  • Lanza GM, Lorenz CH, Fischer SE, Scott MJ, Cacheris WP, Kaufman RJ, Gaffney PJ, Wickline SA. Enhanced detection of thrombi with a novel fibrin targeted magnetic resonance imaging agent. Acad Radiol 1998a; 5(Suppl 1.)S173–S176
  • Lanza GM, Trousil RL, Wallace KD, Rose JH, Hall CS, Scott MJ, Miller JG, Eisenberg PR, Gaffney PJ, Wickline SA. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am 1998b; 104: 3665–3672
  • Lanza GM, Abendschein DR, Hall CS, Marsh JN, Scott MJ, Scherrer DE, Wickline SA. Molecular imaging of stretch induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest Radiol 2000; 35: 227–234
  • Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA. Targeted antiproliferative drug delivery to vascular smooth muscle cells with magnetic resonance imaging nanoparticle contrast agent: Implications for rational therapy of restenosis. Circulation 2002; 106: 2842–2847
  • Lanza GM, Winter PM, Neubauer AM, Caruthers SD, Hockette FD, Wickline SA. (1)H/(19)F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. Curr Top Dev Biol 2005, 70: 57–76
  • Li J, Ng HT, Cassell A, Fan W, Chen H, Ye Q, Koehne J, Han J, Meyyappan M. Carbon nanotube nanoelectrode array for ultrasensitive DNA detection. Nano Lett 2003; 3: 597–602
  • Limpanussorn J, Simon L, Dayan AD. Transepithelial transport of large particles in rat: A new model for the quantitative study of particle uptake. J Pharm Pharmacol 1998; 50: 753–760
  • Liu L, Zern M, Lizarzaburu M, Nantz MH, Wu J. Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver. Gene Ther 2003; 10: 180–187
  • Liu L, Khang G, Rhee J, Lee H. Monolithic osmotic tablet system for nifedipine delivery. J Control release 2000; 67: 309–322
  • Loeb C, Benassi E, Besio G, Maffini M, Tanganelli P. Liposome-entrapped GABA modifies behavioral and electrographic changes of penicillin-induced epileptic activity. Neurology 1982; 32: 1234–1238
  • Loscertales I, Barrero A, Guerrero I, Cortijo R, Marquez M, Ganan-Calvo AM. Micro/nano encapsulation via electrified coaxial liquid jets. Science 2002; 295: 1695–1698
  • Low PS, Antony AC. Folate receptor targeted drugs for cancer and inflammatory diseases. Adv Drug Deliv Rev 2004; 56: 1055–1058
  • Lu Y, Low PS. Folate-mdeiated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 2002; 54: 675–693
  • Lubben IVD, Konings F, Borchard G. In vivo uptake of chitosan microparticles by murine Peyer's patches: Visualization studies using confocal laser scanning microscopy and immunohistochemistry. J Drug Target 2001; 9: 39–47
  • Lutsiak M, Robinson D, Coester C, Kwon GS, Samuel J. Analysis of poly(d,l-lactic- co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharm Res 2002; 19: 1480–1487
  • Maksimento A, Mandroguine V, Gottikh M. Optimisation of dendrimer-mediated gene transfer by anionic oligomers. J Gene Med 2003; 5: 61–71
  • Martin C, Kohli P. The emerging field of nanotube biotechnology. Nat Rev Drug Discov 2002; 2: 29–35
  • Mathiowitz E, Saltzman WM, Domb A, Dor P, Langer R. Polyanhydride microspheres as drug carriers II. Microencapsulation by solvent removal. J Appl Polym Sci 1988; 35: 755–774
  • Mathiowitz E, Jacob JS, Jong YS, Carino G, Chickering DE, Chaturverdi P, Santos CA, Vijayaraghavan K, Montgomery S, Bassett M, Morrell C. Biologically erodible microspheres as potential oral drug delivery systems. Nature 1997; 386: 410–414
  • Mathiowitz E, Chickering D, Jacob M, Santos C. Bioadhesive drug delivery systems. Encyclopedia of controlled drug delivery, E Mathiowitz. Wiley and Sons, New York, NY 1999
  • McIntyre JO, Fingleton B, Wells KS, Piston DW, Lynch CC, Gautam S, Matrisian LM. Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. Biochem J 2004; 377: 617–628
  • McKinnie J. Nanobiotechnology offers a promising solution overcoming common drug delivery failures. Drug Deliv Technol 2006; 5: 11–15
  • McLean S, Prosser E, Meehan E, O'Malley D, Clarke D, Ramtoola Z, Brayden D. Binding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci 1997; 6: 153–163
  • McMinn LH, Hodges GM, Carr KE. Gastrointestinal uptake and translocation of microparticles in the streptozotocin-diabetic rat. J Anat 1996; 189: 533–539
  • McShane M. Potential for glucose monitoring with nanoengineered fluorescent biosensors. Diabetes Technol Ther 2002; 4: 533–538
  • Miyata N, Yamakoshi T. Fullerenes: Recent advances in the chemistry and physics of fullerenes and related materials, KM Kadish, RS Ruoff. Electrochemical Society, Pennington, NJ 1997; vol. 5: 345–357
  • Moghimi SM, Bonnemain B. Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: Applications in lymphoscintigraphy and indirect lymphography. Adv Drug Deliv Rev 1999; 37: 295–312
  • Moghimi SM, Hunter AC. Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm Res 2001; 18: 1–8
  • Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 2001; 53: 283–318
  • Moghimi SM. Modulation of lymphatic distribution of subcutaneously injected poloxamer 407-coated nanospheres: The effect of the ethylene oxide chain configuration. FEBS Lett 2003; 540: 241–244
  • Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 2003; 53: 283–318
  • Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 2003; 42: 463–478
  • Moghimi M, Hunter AC, Murray JC. Nanomedicine: Current status and future prospects. FASEB 2005; 19: 311–330
  • Mori N, Kurokouchi A, Osonoe K, Saitoh H, Ariga K, Suzuki K, Iwata Y. Liposome-entrapped phenytoin locally suppresses amygdaloid epileptogenic focus created by db-cAMP/EDTA in rats. Brain Res 1995; 703: 184–190
  • Murray JC, Moghimi SM. Endothelial cells as therapeutic targets in cancer: New biology and novel delivery systems. Crit Rev Ther Drug Carrier Syst 2003; 20: 139–152
  • Muzykantov VR, Christofidou-Solomidou M, Balyasnikova IV, Harshaw D, Schultz L, Fisher AB, Albelda SM. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet–endothelial cell adhesion molecule-1): A strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci USA 1999; 96: 2379–2384
  • Najlah M, Freeman S, Attwood D, D'Emanuele A. Synthesis, characterization, and stability of dendrimer prodrugs. Int J Pharm 2006a; 308: 1750182
  • Najlah M, Freeman S, Attwood D, D'Emanuele A. In vitro evaluation of dendrimer prodrugs for oral delivery. Int J Pharm 2006b, November 28 epub
  • Nam JM, Thaxton CS, Mirkin CA. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 2003; 301: 1884–1886
  • Nam JM, Stoeva SI, Mirkin CA. Biol-bar-code-based DNA detection with PCR like sensitivity. J Am Chem Soc 2004; 126: 5932–5933
  • Nel A, Xia T, Madler L, Li N. Tox potential of materials at the nanolevel. Science 2006; 311: 622–627
  • Oh P, Li Y, Yu J, Durr E, Krasinka KM, Carver LA, Testa JE, Schnitzer JE. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (London) 2004; 429: 629–635
  • Onodera H, Takada G, Tada K, Desnick RJ. Microautoradiographic study on the tissue localization of liposome-entrapped or unentrapped 3H-labeled beta-galactosidase injected into rats. Tohoku J Exp Med 1983; 140: 1–13
  • Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 12: 329–347
  • Pappo J, Ermak TH. Uptake and translocation of fluorescent latex particles by rabbit peyer's patch follicle epithelium: A quantitative model for M cell uptake. Clin Exp Immunol 1989; 76: 144–148
  • Pardridge WM. The blood–brain barrier: Bottleneck in brain drug development. NeuroRx. 2005; 2: 3–14
  • Pasqualini R, Arap W, McDonald DM. Probing the structural and molecular diversity of tumour vasculature. Trends Mol Med 2002; 8: 563–571
  • Pastorino F, Brignole C, Marimpietri D, Cilli M, Gambini C, Ribatti D, Longhi R, Allen TM, Corti A, Ponzoni M. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Cancer Res 2003; 63: 7400–7409
  • Perez C, Sanchez A, Putnam D, Ting D, Langer R, Alonso MJ. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Control Release 2001; 75: 211–224
  • Ponchel G, Duchêne D. Development of a bioadhesive tablet. High performance biomaterials, M Szycher. Technomic Publishing Company, Inc., Lancaster, PA 1991; 231–242
  • Postmes TJ, Hukkelhoven M, van den Bogaard AE, Halders SG, Coenegracht J. Passage through the blood–brain barrier of thyrotropin-releasing hormone encapsulated in liposomes. J Pharm Pharmacol 1980; 32: 722–724
  • Ramge P, Kreuter J, Lemmer B. Circadian phase-dependent antinociceptive reaction in mice determined by the hot-plate test and the tail-flick test after intravenous injection of dalargin-loaded nanoparticles. Chronobiol Int 1999; 16: 767–777
  • Ran S, Gao B, Duffy S, Watkins L, Rote N, Thorpe PE. Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumour vasculature. Cancer Res 1998; 58: 4646–4653
  • Remaut K, Lucas B, Braeckmans K, Sanders NN, Demeester J, DeSmedt SC. Protection of oligonucleotides against nucleases by pegylated and non-pegylated liposomes as studied by fluorescence correlation spectroscopy. J Control Release 2005; 110: 212–226
  • Roney C, Kulkarni P, Arora V. Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease. J Control Release 2005; 108: 193–214
  • Rosi NL, Mirkin CA. Nanostructures in biodiagnostics. Chem Rev 2005; 105: 1547–1562
  • Ruoslahti E. Drug targeting to specific vascular sites. Drug Discov Today 2002; 7: 1138–1143
  • Sapra P, Allen TM. Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. Cancer Res 2002; 62: 7190–7194
  • Schackert G, Fan D, Nayar R, Fidler I. Arrest and retention of multilamellar liposomes in the brain of normal mice or mice bearing experimental brain metastases. Sel Cancer Ther 1989; 5: 73–79
  • Scherpereel A, Wiewrodt R, Christofidou-Solomidou M, Gervais R, Murciano JC, Albelda SM, Muzykantov VR. Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting. FASEB J 2001; 15: 416–426
  • Schinazi RF, Sijbesma R, Srdanov G, Hill CL, Wudl F. Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene. Antimicrob Agents Chemother 1993; 37: 1707–1710
  • Schinkel A. P-Glycoprotein, a gatekeeper in the blood–brain barrier. Adv Drug Deliv Rev 1999; 36: 179–194
  • Schroder U, Sabel BA. Nanoparticles, a drug carrier system to pass the blood–brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain Res 1996; 710: 121–124
  • Schroeder U, Sommerfeld P, Ulrich S, Sabel BA. Nanoparticle technology for delivery of drugs across the blood–brain barrier. J Pharm Sci 1998; 87: 1305–1307
  • Shi N, Zhang Y, Zhu C, Boado RJ, Pardridge WM. Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci USA 2001; 98: 12754–12759
  • Silva GA. Neuroscience nanotechnology: Progress, opportunities and challenges. Nat Rev Neurosci 2006; 7: 65–74
  • Singh R, Pantarotto D, Lacerdo L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 2006; 103: 3357–3362
  • Sinha J, Das N, Basu MK. Liposomal antioxidants in combating ischemia-reperfusion injury in rat brain. Biomed Pharmacother 2001; 55: 264–271
  • St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW. Genes expressed in human tumor endothelium. Science 2000; 289: 1197–1202
  • Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000; 41: 147–162
  • Sumner JP, Aylott JW, Monson E, Kopelman R. A fluorescent PEBBLE nanosensor for intracellular free zinc. Analyst 2002; 127: 11–16
  • Tabata Y, Murakami Y, Ikada Y. Photodynamic effect of polyethylene glycolmodified fullerene on tumor. Jpn J Cancer Res 1997a; 88: 1108–1116
  • Tabata Y, Murakami Y, Ikada Y. Antitumor effect of poly(ethylene glycol)-modified fullerene. Fullerene Sci Technol 1997b; 5: 989–1007
  • Taton TA, Mirkin CA, Letsonger RL. Scanometric DNA array detection with nanoparticle probes. Science 2000; 289: 1757–1760
  • Thanos C, Liu Z, Goddard M, Reineke J, Bailey N, Cross M, Burrill R, Mathiowitz E. Enhancing the oral bioavailability of the poorly soluble drug dicumarol with a bioadhesive polymer. J Pharm Sci 2003a; 92: 1677–1689
  • Thanos C, Liu Z, Reineke J, Edwards E, Mathiowitz E. Improving relative bioavailability of dicumarol by reducing particle size and adding the adhesive poly(fumaric-co-sebacic) anhydride. Pharm Res 2003b; 20: 1093–1100
  • Tiwri SB, Amuji MM. A review of nanocarrier-based CNS delivery systems. Curr Drug Deliv 2006; 3: 219–232
  • Tokes ZA, St Peteri AK, Todd JA. Availability of liposome content to the nervous system. Liposomes and the blood–brain barrier. Brain Res 1980; 188: 282–286
  • Torche A, Jouan H, Corre PL, Chevanne F, Le Verge R. Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment. Int J Pharm 2000; 201: 15–27
  • Torchillin VP, Lukyanov AN, Gao ZG. Papahadjopoulos-Sternberg B. Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA 2003; 100: 6039–6044
  • Tsao N, Kanakaama PP, Luh TY, Chou CK, Lei HY. Inhibition of Escherichia coli-induced meningitis by carboxyfullerence. Antimicrob Agents Chemother 1999; 43: 2273–2277
  • Tsao N, Luh TY, Chou CK, Wu JJ, Lin YS, Lei HY. Inhibition of group A streptococcus infection by carboxyfullerene. Antimicrob Agents Chemother 2001; 45: 1788–1793
  • Turunen MP, Puhakka HL, Koponen JK, Hiltunen MO, Rutanen J, Leppanen O, Turunen AM, Narvanen A, Newby AC, Baker AH. Peptide re-targeted adenovirus encoding a tissue inhibitor of metalloproteinase-1 decreases restenosis after intravascular gene transfer. Mol Ther 2002; 6: 306–312
  • Tziveleka LA, Kontoyianni C, Sideratou Z, Tsiourvas D, Paleos CM. Novel hyperbranched polyether polyols as prospective drug delivery systems. Macromol Biosci 2006; 6: 161–169
  • Varde NK, Pack DW. Microspheres for controlled release drug delivery. Expert Opin Biol Ther 2004; 4: 35–51
  • Vasir JK, Labhasetwar V. Targeted drug delivery in cancer therapy. Technol Cancer Res Treat 2005; 25: 363–374
  • VisionGain. Drug delivery 2003 new technologies in the global market. 2003, VisionGain, June
  • Walovitch R, Kwan O, Picard M. 2003. Initial safety and myocardial perfusion imaging results with AI-700: A new ultrasound contrast agent, http://www.acusphere.com/ab_5.html
  • Wang J, Musameh M. Carbon nanotube/teflon composite electrochemical sensors and biosensors. Anal Chem 2003; 75: 2075–2079
  • Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005; 11: 1418–1423
  • Wickline SA, Lanza GM. Nanotechnology for molecular imaging and targeted therapy. Circulation 2003; 107: 1092–1095
  • Win K, Feng S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005; 26: 2713–2722
  • Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang HY, Robertson JD, Wickline SA. Molecular imaging of angiogenesis in nascent vx-2 rabbit tumours using a novel alpha(v)beta(3)-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 2003; 63: 5838–5843
  • Woolley AT, Guillemette C, LiCheung C, Housman DE, Lieber CM. Direct haplotyping of kilobase-size DNA using carbon nanotube probes. Nat Biotechnol 2000; 18: 760–763
  • Wunderbaldinger P, Josephson L, Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem 2002; 13: 264–268
  • Yang J, Mayer M, Kriebel JK, Garstecki P, Whitesides GM. Self-assembled aggregates of IgGs as templates for the growth of clusters of gold nanoparticles. Angew Chem Int Ed Engl 2004; 43: 1555–1558
  • Yong CS, Lee MK, Park YJ, Kong KH, Xuan JJ, Kim JH, Kim JA, Lyoo WS, Han SS, Rhee JD, Kim JO, Yang CH, Kim CK, Choi HG. Enhanced oral bioavailability of ibuprofen in rats by poloxamer gel using poloxamer 188 and menthol. Drug Dev Ind Pharm 2005; 31: 615–622
  • Yu X, Song S-K, Chen J, Scott MJ, Fuhrhop RJ, Hall CS, Gaffney PJ, Wickline SA, Lanza GM. High resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000; 44: 867–872
  • Zara GP, Bargoni A, Cavalli R, Fundaro A, Vighetto D, Gasco MR. Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats. J Pharm Sci 2002; 91: 1324–1333
  • Zara GP, Cavalli R, Bargoni A, Fundaro A, Vighetto D, Gasco MR. Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: Pharmacokinetics and distribution of doxorubicin in brain and other tissues. J Drug Target 2004; 10: 327–335
  • Zhang Y, Schlachetzkif F, Pardridge W. Global non-viral gene transfer to the primate brain following intravenous administration. Mol Ther 2003; 7: 11–18
  • Zitzmann S, Ehemann V, Schwab M. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res 2002; 62: 5139–5143

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.